Atogepant Uses, Dosage, Side Effects and more
Atogepant is under investigation in clinical trial NCT03855137 (Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine).
| Trade Name | Atogepant |
| Availability | Prescription only |
| Generic | Atogepant |
| Atogepant Other Names | Atogepant |
| Related Drugs | propranolol, atenolol, topiramate, nifedipine, Depakote, verapamil |
| Type | |
| Formula | C29H23F6N5O3 |
| Weight | Average: 603.525 Monoisotopic: 603.170508599 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Drug Interaction
Minor: acetaminophen / butalbital / caffeineUnknown: fremanezumab, onabotulinumtoxinA, benztropine, prochlorperazine, ubiquinone, duloxetine, galcanezumab, fluticasone nasal, chondroitin / glucosamine / methylsulfonylmethane, haloperidol, polyethylene glycol 3350, rimegepant, bismuth subsalicylate, lasmiditan, ubrogepant, diazepam, cyanocobalamin, ascorbic acid, cholecalciferol
